Table 2 Secondary Outcomes†
Hydrotherapy | Land Exercises | |||||
|---|---|---|---|---|---|---|
Outcome Measure | Baseline N = 57 | Immediately Post Treatment N = 44 | 3 mo. post treatment N = 43 | Baseline N = 58 | Immediately Post Treatment N = 40 | 3 mo. Post treatment N = 42 |
EQ-5D Utility | 0.69 (0.52–0.80) | 0.69 (0.59–0.78) p = 0.61 | 0.62 (0.52–0.76) p = 0.044 | 0.69 (0.59–0.76) | 0.68 (0.59–0.79) p = 0.57 | 0.66 (0.52–0.76) p = 0.044 |
EQ-5D VAS (0–100) | 70 (50–85) | 73 (55–85)** p = 0.57 | 70 (44–80) p = 0.08 | 74 (60–86)* | 77 (60–90) p = 0.42 | 75 (51–88)*** p = 0.63 |
HAQ (0–3) | 1.38 (0.69–2.00) | 1.50 (1.06–1.84) p = 0.09 | 1.63 (1.13–1.88) p = 0.23 | 1.50 (0.88–2.00)* | 1.44 (0.78–1.84) p = 0.20 | 1.38 (0.84–1.91) p = 0.77 |
Pain (100 mm VAS, 0 = no pain) | 24 (10–50) | 25.5 (11–41) p = 0.40 | 35 (14–62) p = 0.026 | 26.5 (14–51) | 27.5 (15–58) p = 0.22 | 42.5 (16–59) p = 0.005 |
10 m walk time (seconds) | 10.9 (7.9–12.8) | 9.1 (7.2–10.7) p < 0.001 | 10.0 (8.0–12.0)** p = 0.011 | 10.2 (8.8–13.2) | 8.8 (6.9–11.3) p < 0.001 | 9.0 (7.7–11.3) p < 0.001 |